Search

Now showing items 1-10 of 65

A multi-gene signature predicts outcome in patients with pancreatic ductal adenocarcinoma

Haider, S; Wang, J; Nagano, A; Desai, A; Arumugam, P; Dumartin, L; Fitzgibbon, J; Hagemann, T; Marshall, JF; Kocher, HM;... (2014)

Improved usage of the repertoires of pancreatic ductal adenocarcinoma (PDAC) profiles is crucially needed to guide the development of predictive and prognostic tools that could inform the selection of treatment options.

A multi-gene signature predicts outcome in patients with pancreatic ductal adenocarcinoma.

Haider, S; Wang, J; Nagano, A; Desai, A; Arumugam, P; Dumartin, L; Fitzgibbon, J; Hagemann, T; Marshall, JF; Kocher, HM;... (2014)

The Pancreatic Expression Database: 2018 update.

Marzec, J; Dayem Ullah, AZ; Pirrò, S; Gadaleta, E; Crnogorac-Jurcevic, T; Lemoine, NR; Kocher, HM; Chelala, C (2018-01-04)

The Pancreatic Expression Database (PED, http://www.pancreasexpression.org) continues to be a major resource for mining pancreatic -omics data a decade after its initial release. Here, we present recent updates to PED and ...

PAK4 interacts with p85 alpha: implications for pancreatic cancer cell migration

King, H; Thillai, K; Whale, A; Arumugam, P; Eldaly, H; Kocher, HM; Wells, CM (2017-02-16)

Limited utility of inflammatory markers in the early detection of postoperative inflammatory complications after pancreatic resection: Cohort study and meta-analyses

Solaini, L; Atmaja, BT; Watt, J; Arumugam, P; Hutchins, RR; Abraham, AT; Bhattacharya, S; Kocher, HM (2015-05)

Reduced Expression of Histone Methyltransferases KMT2C and KMT2D Correlates with Improved Outcome in Pancreatic Ductal Adenocarcinoma

Dawkins, JBN; Wang, J; Maniati, E; Heward, JA; Koniali, L; Kocher, HM; Martin, SA; Chelala, C; Balkwill, FR; Fitzgibbon, J;... (2016-08-15)

A global insight into a cancer transcriptional space using pancreatic data: importance, findings and flaws

Gadaleta, E; Cutts, RJ; Kelly, GP; Crnogorac-Jurcevic, T; Kocher, HM; Lemoine, NR; Chelala, C (2011-10)

Anti-stromal treatment together with chemotherapy targets multiple signalling pathways in pancreatic adenocarcinoma

Carapuca, EF; Gemenetzidis, E; Feig, C; Bapiro, TE; Williams, MD; Wilson, AS; Delvecchio, FR; Arumugam, P; Grose, RP; Lemoine, NR;... (2016-07)

Stromal SPOCK1 supports invasive pancreatic cancer growth

Veenstra, VL; Damhofer, H; Waasdorp, C; Steins, A; Kocher, HM; Medema, JP; van Laarhoven, HW; Bijlsma, MF (2017-08)

Unravelling the pharmacologic opportunities and future directions for targeted therapies in gastro-intestinal cancers part 2: Neuroendocrine tumours, hepatocellular carcinoma, and gastro-intestinal stromal tumours.

Neuzillet, C; de Mestier, L; Rousseau, B; Mir, O; Hebbar, M; Kocher, HM; Ruszniewski, P; Tournigand, C (2018-01)

Until the 1990s, cytotoxic chemotherapy has been the cornerstone of medical therapy for gastrointestinal (GI) cancers. Better understanding of the cancer cell molecular biology has led to the therapeutic revolution of ...

1
2
3
4
. . .
7